← Back to Search

N/A

ECIG for Inflammation

N/A
Waitlist Available
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in tpe/qtc after cigarette use
Awards & highlights

Study Summary

This trial looked at the effects of smoking an electronic cigarette or a tobacco cigarette on the heart. The results showed that smoking an electronic cigarette is better for the heart than smoking a tobacco cigarette.

Eligible Conditions
  • Inflammation
  • Nicotine Addiction
  • Smoking
  • Tobacco Smoking
  • Long QT Syndrome
  • E-Cigarette Use
  • Vaping
  • HIV
  • Stress Oxidative

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in tpe 5 minutes after cigarette use
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in tpe 5 minutes after cigarette use for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Total Cellular Reactive Oxygen Stress
Tpe
Tpe/QT
+1 more
Secondary outcome measures
QT
QTc

Trial Design

1Treatment groups
Experimental Treatment
Group I: PLWH smokerExperimental Treatment3 Interventions
PLWH who smoke will undergo 3 interventions : acute TCIG use, acute ECIG use and acute sham control

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,538 Previous Clinical Trials
10,266,994 Total Patients Enrolled
26 Trials studying Inflammation
2,811 Patients Enrolled for Inflammation
Tobacco Related Disease Research ProgramOTHER
25 Previous Clinical Trials
20,581 Total Patients Enrolled
1 Trials studying Inflammation
148 Patients Enrolled for Inflammation

Media Library

ECIG (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT04568395 — N/A
Inflammation Research Study Groups: PLWH smoker
Inflammation Clinical Trial 2023: ECIG Highlights & Side Effects. Trial Name: NCT04568395 — N/A
ECIG (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04568395 — N/A
Inflammation Patient Testimony for trial: Trial Name: NCT04568395 — N/A
~8 spots leftby Jun 2025